Clinicopath Conf
Primary (Granulomatous) Angiitis of Central Nervous System, Case Record 8-1989, NEJM 320:514-5249., , 1989
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Oligoclonal IgG Bands in Cerebrospinal Fluid in Various Neurological Diseases
Ann Neurol 13:434-439, Chu,A.B.,et al, 1983
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Neurosyphilis
Ann Neurol 98:1070-1076, Minter,D.J. & Chow,F.C., 2025
Characteristics in Limbic Encephalitis with Anti-Adenylate Kinase 5 Autoantibodies
Neurol 88:514-524,508, Do, L. & Chanson, E., 2017
Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples
JAMA Neurol 74:155-162,144, Bongianni, M.,et al, 2017
Cerebrospinal Fluid Real-Time Quaking-Induced Conversion is a Robust and Reliable Test for Sporadic Creutzfeldt-Jakob Disease: An International Study
Ann Neurol 80:160-165, McGuire, L.I.,et al, 2016
Differentiation Between Traumatic Tap and Aneurysmal Subarachnoid Hemorrhage: Prospective Cohort Study
BMJ 350:h568, Perry, J.J.,et al, 2015
Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid
mBio 6:e02451-14, Orru,C.D.,et al, 2015
Time-Dependent Test Characteristics of Head Computed Tomography in Patients Suspected of Nontraumatic Subarachnoid Hemorrhage
Stroke 43:2115-2119, Backes, D.,et al, 2012
CSF biomarkers in posterior cortical atrophy
Neurol 76:1782-1788, Seguin, J.et al, 2011
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD
Neurol 75:143-151, Vemuri,P., et al, 2010
CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009
Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008
CSF Analysis in Patients With Sporadic CJD and Other Transmissible Spongiform Encephalopathies
Eur J Neurol 14:121-124, Green,A.,et al, 2007
The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007
Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Stroke 37:256-262, Steiner, T.,et al, 2006
Aneurysmal Subarachnoid Hemorrhage
NEJM 354:387-396, Suarez,J.I.,et al, 2006
Subarachnoid Haemorrhage
BMJ 333:235-240, Al-Shahi,R.,et al, 2006
CSF Tests in the Differential Diagnosis of Cretuzfeldt-Jakob Disease
Neurol 67:637-643, Sanchez-Juan,P.,et al, 2006
Aneurysmal Subarachnoid Leak With Normal CT and CSF Spectrophotometry
Neurol 64:923, McCarron, M.O. & Choudhari, K.A., 2005
Clearing of Red Blood Cells in Lumbar Puncture Does Not Rule Out Ruptured Aneurysm in Patients with Suspected Subarachnoid Hemorrhage but Negative Head CT Findings
AJNR 26:820-824, Heasley,D.C.,et al, 2005
Neurosyphillis in the Modern Era
JNNP 75:1727-1730, Timmermans,M. &Carr,J., 2004
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002
Anthrax meningoencephalitis
Neurol 59:327-334,300, Lanska,D.J., 2002
Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Avoiding Pitfalls in the Diagnosis of Subarachnoid Hemorrhage
NEJM 342:29-36, Edlow,J.A.&Caplan,L.R., 2000
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999
Early Diagnosis of Central Nervous System Aspergillosis With Combination Use of Cerebral Diffusion-Weighted Echo-Planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
Internal Medicine 38:45-48, Kami,M.,et al, 1999
Detection of 14-3-3 Protein in Cerebrospinal Fluid Supports Dx of Creutzfeldt-Jakob Disease
Ann Neurol 43:32-40, Zerr,I.,et al, 1998
Longitudinal Study of CSF Levels of Tau, A beta 1-40, and A beta 1-42 (43) in Alzheimer's Disease
Ann Neurol 44:17-26, 61998., Kanai,M.,et al, 1998
Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997
Assessment of CSF Levels of Tau Protein in Mildly Demented Patients with Alzheimer's Disese
Neurol 48:632-635, Galasko,D.,et al, 1997
The 14-3-3 Brain Protein and Transmissible Spongiform Encephalopathy
NEJM 336:873-875, Moussavian,M.,et al, 1997
Detection of 14-3-3 Protein in the CSF of Genetic Creutzfeldt-Jakob Disease
Neurol 49:593-595, Rosemann,H.,et al, 1997
Relationship Between Human Immunodeficiency Virus-Associated Dementia & Viral Load in Cerebrospinal Fluid & Brain
Ann Neurol 42:689-698, 6751997., McArthur,J.C.,et al, 1997
Cerebrovascular complic of Neurocysticercosis, Clin & Neuroimaging Spectrum
Arch Neurol 53:233-239, Cantu,C.&Barinagarrementeria,F., 1996
Leukoencephalopathy-Related Cerebral Amyloid Angiopathy with Cystatin C Deposition
Stroke 27:1417-1419, Shimode,K.,et al, 1996
Bovine Spongiform Encephalopathy and Creutzfeldt-Jakob Disease
BMJ 312:790-791, Brown,P., 1996
Varicalla-Zoster Virus DNA in CSF & Arteries in Delayed Contralat Hemiplegia:Evid for Viral Invasion of Cerebr Art
Neurol 47:569-570, Melanson,M.,et al, 1996
Apolipoprotein E Phenotype Freq & CSF Concentra are not Assoc with Creutzfeldt-Jakob Disease
Arch Neurol 53:1233-1238, Zerr,I.,et al, 1996
The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
NEJM 335:924-930, 9631996., Hsich,G.,et al, 1996